Position in ARQT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,945,859
+$3,651,159 QoQ
Shares Held
264,907
+89.4% QoQ
Ownership
0.211%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 271 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in ARQT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. ARQT ranks #67 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in ARQT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,945,859 | 264,907 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $3,294,700 | 139,843 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $8,926,372 | 307,382 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $3,637,144 | 192,952 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,397,835 | 99,703 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,784,837 | 1,328,954 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $15,694,483 | 1,126,668 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $8,727,900 | 938,484 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,719,623 | 937,594 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $8,644,928 | 872,344 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $81,189 | 25,136 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $133,137 | 25,073 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $241,289 | 25,319 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $264,330 | 24,030 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $249,157 | 16,835 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $355,846 | 18,621 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,457,518 | 209,175 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $216,848 | 11,259 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $229,383 | 11,060 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $313,292 | 13,114 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $329,799 | 12,085 | Shares | Defined | 2021-08-17 | |
| No filing history on record for this holder in this stock. | ||||||